Top 7 Diagnostic Innovations Shaping the Human Cystatin C Assay Kit Industry According to a newly published market research report by 24LifeSciences, global Human Cystatin C Assay Kit market was valued at USD 215 million in 2026 and is projected to reach USD 367 million by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. Human Cystatin C Assay Kits are in-vitro diagnostic tools designed to quantitatively measure the level of Cystatin C, a low molecular weight protein, in human serum or plasma. This biomarker is a crucial and highly sensitive indicator for assessing glomerular filtration rate (GFR), offering a more reliable alternative to traditional creatinine-based tests. Because of its consistent production rate and minimal influence by muscle mass, age, or diet, Cystatin C is increasingly recognized as a superior marker for early detection of renal impairment across diverse patient populations. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9947/human-cystatin-c-assay-kit-market